-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Blood Buddies: Future of Hematology (Artificial Intelligence)

Symposia: ASH-a-Palooza Program: Trainee Activities and Services
Friday, December 6, 2024: 1:30 PM-3:50 PM
Café Sevilla Restaurant (Gaslamp Quarter)
Panelists:
Torsten Haferlach, MD, MLL Munich Leukemia Laboratory , Sanjay Ahuja, MD, Rainbow Babies and Children's Hospital , Barbara D Lam, MD, Beth Israel Deaconess Medical Center , Moses Miles, ATHN , Roni Shouval, MD, PhD, Memorial Sloan Kettering Cancer Center and Jordan Gauthier, MD, MSc, Fred Hutchinson Cancer Center
Disclosures:
Ahuja: US FDA: Honoraria, Other: Member of the Blood Products Advisory Committee; Case Western Reserve University: Patents & Royalties: Patent for US 11,408,844 issued; XaTek: Membership on an entity's Board of Directors or advisory committees, Research Funding; CSL Behring: Honoraria, Membership on an entity's Board of Directors or advisory committees; BioMarin: Honoraria, Membership on an entity's Board of Directors or advisory committees; Sanofi Genzyme: Honoraria, Membership on an entity's Board of Directors or advisory committees; Genentech: Honoraria, Membership on an entity's Board of Directors or advisory committees; Governor’s Office, State of Ohio: Other: Membership on Rare Disease Advisory Council for the State of Ohio. Gauthier: Sobi, Juno Therapeutics, a BMS company, Celgene, and Angiocrine Bioscience: Research Funding; Sobi, Legend Biotech, Janssen, Kite Pharma, a Gilead company, and MorphoSys: Consultancy.

Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical Education; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.